Literature DB >> 22828230

[The role of the quality of hospital discharge records on the comparative evaluation of outcomes: the example of chronic obstructive pulmonary disease (COPD)].

Valeria Fano1, Mariangela D'Ovidio, Katiuscia del Zio, Davide Renzi, Daniela Tariciotti, Nera Agabiti, Lucia Argenti, Maria Sofia Cattaruzza, Antonio Fortino.   

Abstract

OBJECTIVE: To analyse the results of the regional comparative evaluation of the outcome "thirty days mortality after admission for reacutized Chronic obstructive pulmonary disease (COPD)" before and after a reabstract study.
DESIGN: Reabstract study of clinical records included in the regional comparative evaluation. SETTING AND PARTICIPANTS: 232 clinical records retrieved from Grassi Hospital archives (years 2006-2007) and reviewed by two physicians and one nurse specifically trained. MAIN OUTCOME MEASURES: Models performed before and after reabstract study for comparative evaluation of the outcome were compared. Blind coding of diagnosis and interventions/procedures was completed according to a standard grid consistent with regional guidelines for Hospital Discharge Record coding. Other information was registered, if present on discharge record: smoking habit, number of reacutizations occurred within previous year, use of oxigen and/or other therapies, pneumological visit at discharge.
RESULTS: The majority (94%) of reviewed cases were confirmed as being cases of COPD. A total of 168 cases (72%) have been identified as reacutized COPD coherent with enrolment criteria of regional program, 49 (21%) have been identified as COPD and only 15 cases (6%) resulted not affected by COPD. Results of the regional comparative model were substantially unchanged for Grassi hospital (RR =23 vs RR =24). Accurateness of clinical documentation resulted inadequate especially regarding information at discharge (50% missing information on smoking habit, 83% on previous year reacutizations, 22% on follow-up organization after discharge).
CONCLUSION: This study contributes to the debate on the role of administrative data on the comparative evaluation of health outcomes. Other relevant issues are to promote the collaboration among different health professionals working in the same hospital, and to increase the awareness of the importance of the quality of health and administrative data.

Entities:  

Mesh:

Year:  2012        PMID: 22828230

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  4 in total

1.  Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol.

Authors:  Iosief Abraha; Diego Serraino; Gianni Giovannini; Fabrizio Stracci; Paola Casucci; Giuliana Alessandrini; Ettore Bidoli; Rita Chiari; Roberto Cirocchi; Marcello De Giorgi; David Franchini; Maria Francesca Vitale; Mario Fusco; Alessandro Montedori
Journal:  BMJ Open       Date:  2016-03-25       Impact factor: 2.692

2.  The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.

Authors:  Valeria Belleudi; Mirko Di Martino; Silvia Cascini; Ursula Kirchmayer; Riccardo Pistelli; Giulio Formoso; Danilo Fusco; Marina Davoli; Nera Agabiti
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-07-11       Impact factor: 2.890

3.  Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: the Umbria Data Value Project.

Authors:  Francesco Cozzolino; Iosief Abraha; Massimiliano Orso; Anna Mengoni; Maria Francesca Cerasa; Paolo Eusebi; Giuseppe Ambrosio; Alessandro Montedori
Journal:  BMJ Open       Date:  2017-03-29       Impact factor: 2.692

4.  One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study.

Authors:  Ursula Kirchmayer; Silvia Cascini; Nera Agabiti; Mirko Di Martino; Lisa Bauleo; Giulio Formoso; Claudio Voci; Riccardo Pistelli; Elisabetta Patorno; Marina Davoli
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-29       Impact factor: 2.890

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.